Home › Companies › Gossamer Bio, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Gossamer Bio, Inc.’s Form 8-K, filed 2026-06-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2025-2026
Explore Gossamer Bio, Inc. in the interactive database Compare manager voting policies
These tallies are Gossamer Bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Faheem Hasnain | 92,301,637 | -- | -- | 26,667,876 | 45,450,098 | Majority: yes |
| Elect Director: Russell Cox | 88,975,980 | -- | -- | 29,993,533 | 45,450,098 | Majority: yes |
| Proposal 2: The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | 163,185,993 | 1,192,448 | 41,170 | -- | -- | Majority: yes |
| Proposal 3: The approval, on an advisory basis, of the compensation of the Company's named executive officers. | 111,286,550 | 7,545,502 | 137,461 | -- | 45,450,098 | Majority: yes |
Source: Gossamer Bio, Inc., Form 8-K, filed with the SEC on 2026-06-05 — read the filing on EDGAR.
Each item below shows how the 135 asset managers that disclosed a Gossamer Bio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Gossamer Bio, Inc.’s own tally for this item (“Proposal 3: The approval, on an advisory basis, of the compensation of the Company's named executive officers.”): 111,286,550 for, 7,545,502 against, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 234,696,281 outstanding shares: 47.4% for, 3% against (50.6% of the company cast a for/against vote).
The 133 asset managers below cast 95% of the shares they voted on this item FOR (102,029,410 for, 5,665,924 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kalehua Capital Management LLC | 9,975,292 | 0 | 0 | 0 | For |
| BlackRock | 9,639,058 | 1,450 | 0 | 0 | For |
| ARCH Venture Management, LLC | 8,055,916 | 0 | 0 | 0 | For |
| AQR | 7,819,857 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 7,700,342 | 0 | 0 | 0 | For |
| Samsara BioCapital, LLC | 7,222,559 | 0 | 0 | 0 | For |
| Vanguard | 5,474,488 | 6,569 | 0 | 0 | For |
| Siren, L.L.C. | 5,118,074 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 4,995,373 | 0 | 0 | 0 | For |
| HHLR ADVISORS, LTD. | 4,974,041 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,272,581 | 0 | 0 | 0 | For |
| State Street | 3,859,355 | 1,475 | 0 | 0 | For |
| Fidelity | 3,614,104 | 0 | 0 | 0 | For |
| Two Sigma | 2,484,406 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 2,174,633 | 0 | 0 | Against |
| ACADIAN ASSET MANAGEMENT LLC | 2,131,047 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 1,940,489 | 0 | 0 | Against |
| Voya | 1,900,094 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 1,702,125 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 1,254,460 | 0 | 0 | 0 | For |
| Charles Schwab | 1,251,967 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,247,385 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,000,000 | 0 | 0 | 0 | For |
| Northern Trust | 736,781 | 0 | 0 | 0 | For |
| Corient Private Wealth LP | 721,020 | 0 | 0 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Combines 5 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Russell Cox”): 88,975,980 for, 29,993,533 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 234,696,281 outstanding shares: 38% for, 13% withheld (50.7% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (16,776,841 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,876,461 | 0 | 0 | 0 | For |
| Vanguard | 5,217,603 | 0 | 19,841 | 0 | For |
| Fidelity | 3,579,473 | 0 | 0 | 0 | For |
| Voya | 950,047 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 625,721 | 0 | Abstain |
| Invesco | 413,558 | 0 | 0 | 0 | For |
| Equitable | 61,926 | 0 | 122,150 | 0 | Abstain |
| Goldman Sachs | 180,037 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 159,516 | 0 | Abstain |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 145,404 | 0 | Abstain |
| Lincoln Financial | 138,600 | 0 | 0 | 0 | For |
| TIAA | 132,894 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 114,037 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 93,852 | 0 | Abstain |
| Global X | 0 | 0 | 84,051 | 0 | Abstain |
| ETFis Series Trust I | 0 | 0 | 72,154 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 69,152 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 54,021 | 0 | Abstain |
| State Street | 47,303 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 46,319 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 0 | 0 | 42,900 | 0 | Abstain |
| Bridge Builder Trust | 36,524 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 27,319 | 0 | Abstain |
| Pacific Life | 18,233 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 17,586 | 0 | Abstain |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 5 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Faheem Hasnain”): 92,301,637 for, 26,667,876 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 234,696,281 outstanding shares: 39% for, 11% withheld (50.7% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (16,861,827 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,876,461 | 0 | 0 | 0 | For |
| Vanguard | 5,217,611 | 0 | 19,833 | 0 | For |
| Fidelity | 3,579,473 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 950,047 | 0 | Abstain |
| Charles Schwab | 625,721 | 0 | 0 | 0 | For |
| Invesco | 413,558 | 0 | 0 | 0 | For |
| Equitable | 184,076 | 0 | 0 | 0 | For |
| Goldman Sachs | 180,037 | 0 | 0 | 0 | For |
| SEI | 159,516 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 145,404 | 0 | Abstain |
| Lincoln Financial | 138,600 | 0 | 0 | 0 | For |
| TIAA | 132,894 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 114,037 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 93,852 | 0 | Abstain |
| Global X | 84,051 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 72,154 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 69,152 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 54,021 | 0 | Abstain |
| State Street | 47,303 | 0 | 0 | 0 | For |
| Russell Investments | 46,319 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 42,900 | 0 | Abstain |
| Bridge Builder Trust | 36,524 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 27,319 | 0 | Abstain |
| Pacific Life | 18,233 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 17,586 | 0 | Abstain |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Gossamer Bio, Inc.’s own tally for this item (“Proposal 2: The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 163,185,993 for, 1,192,448 against, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 234,696,281 outstanding shares: 70% for, 0.6% against (70% of the company cast a for/against vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (18,456,466 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,876,461 | 0 | 0 | 0 | For |
| Vanguard | 5,237,443 | 0 | 0 | 0 | For |
| Fidelity | 3,579,473 | 0 | 0 | 0 | For |
| Voya | 950,047 | 0 | 0 | 0 | For |
| Charles Schwab | 625,721 | 0 | 0 | 0 | For |
| Invesco | 413,558 | 0 | 0 | 0 | For |
| Equitable | 184,076 | 0 | 0 | 0 | For |
| Goldman Sachs | 180,037 | 0 | 0 | 0 | For |
| SEI | 159,516 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 145,404 | 0 | 0 | 0 | For |
| Lincoln Financial | 138,600 | 0 | 0 | 0 | For |
| TIAA | 132,894 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 114,037 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 93,852 | 0 | 0 | 0 | For |
| Global X | 84,051 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 72,154 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 69,152 | 0 | 0 | 0 | For |
| John Hancock | 54,021 | 0 | 0 | 0 | For |
| State Street | 47,303 | 0 | 0 | 0 | For |
| Russell Investments | 46,319 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 42,900 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 36,524 | 0 | 0 | 0 | For |
| DWS | 27,319 | 0 | 0 | 0 | For |
| Pacific Life | 18,233 | 0 | 0 | 0 | For |
| Principal | 17,586 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Ranked by the number of Gossamer Bio, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 234,696,281 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Kalehua Capital Management LLC | 4.25% |
| 2 | BlackRock | 4.11% |
| 3 | ARCH Venture Management, LLC | 3.43% |
| 4 | AQR | 3.33% |
| 5 | Octagon Capital Advisors LP | 3.28% |
| 6 | Samsara BioCapital, LLC | 3.08% |
| 7 | Vanguard | 2.34% |
| 8 | Siren, L.L.C. | 2.18% |
| 9 | 683 Capital Management, LLC | 2.13% |
| 10 | HHLR ADVISORS, LTD. | 2.12% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| 683 Capital Management, LLC | 21.25% | 13G |
| Context Capital Management, LLC | 20.81% | 13G |
| DeepCurrents Investment Group LLC | 16.05% | 13G |
| D. E. Shaw Valence Portfolios, L.L.C. | 11.80% | 13D |
| Opaleye Management Inc. | 10.63% | 13G |
| BlackRock | 7.17% | 13F |
| Vanguard Group | 5.49% | 13F |
| Geode Capital | 2.10% | 13F |
| Two Sigma | 2.04% | 13F |
| State Street | 1.87% | 13F |
Percentages above are of 234,696,281 shares outstanding, as reported by Gossamer Bio, Inc. on its Form 10-Q dated 2026-05-12 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Gossamer Bio, Inc.’s 10-Q dated 2026-05-12. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Gossamer Bio, Inc.'s shareholder meeting held 2026-06-04, in the 2025-2026 proxy season, 135 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 604 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Gossamer Bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-05.
Gossamer Bio, Inc. proxy season coverage: 2025-2026 (this page).